Equity Overview
Price & Market Data
Price: $2.40
Daily Change: -$0.15 / 6.25%
Daily Range: $2.40 - $2.54
Market Cap: $73,170,555
Daily Volume: 47,202
Performance Metrics
1 Week: -4.76%
1 Month: -18.64%
3 Months: -15.49%
6 Months: -12.73%
1 Year: -65.86%
YTD: -40.15%
Company Details
Employees: 92
Sector: Health technology
Industry: Biotechnology
Country:
Details
XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases. It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation. The company was incorporated in 2005 and is headquartered in Austin, Texas.